Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Salvage From Liver Donors (BLEED)
NCT05835882Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of donor-derived red blood cell concentrates in liver transplantation, sponsored by Policlinico Gemelli. Primary endpoint: Number and percentage of LT recipients successfully transplanted with internal donors, who received donor RBC concentrates for the intraoperative transfusion support during liver transplant. Started Jun 2023; status: completed.
02
Drugs
donor-derived red blood cell concentrates
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT05835882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05835882.